Secondary Logo

Journal Logo

UROGYNECOLOGY: Edited by Kavita Mishra

Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women

Wallace, Shannon L.a; Miller, Lucia D.b; Mishra, Kavitaa

Author Information
Current Opinion in Obstetrics and Gynecology: December 2019 - Volume 31 - Issue 6 - p 485–493
doi: 10.1097/GCO.0000000000000584
  • Free



Pelvic floor physical therapy (PFPT), also referred to as pelvic floor muscle training (PFMT), is a conservative, first-line treatment for many pelvic floor disorders [1▪]. PFPT is a general term for the instruction of pelvic muscle strengthening, relaxation, and coordination exercises by a trained physical therapist [2] (Table 1). PFPT may involve manual therapy, biofeedback or electrical stimulation, behavioral education, and the creation of home exercise programs [3]. PFPT has robust evidence-based support as a first-line, minimally invasive option to treat pelvic floor dysfunction, including pelvic organ prolapse (POP), fecal or urinary incontinence, peripartum and postpartum pelvic floor dysfunction and chronic pelvic pain [4–6]. In this review, we will describe pelvic floor disorders that may benefit from a trial of PFPT and discuss the evidence for these treatments.

Table 1
Table 1:
Pelvic floor physical therapy training and certification
Box 1
Box 1:
no caption available


DeLancey [7] and Norton [8] argued that when the pelvic floor muscles have normal strength and tone, the pelvic organs are supported with limited tension on the ligaments and fascia of the pelvis. These pelvic floor muscles may become stretched during childbirth, weak during aging, or hypertonic with increased stress, eventually leading to pelvic floor dysfunction. Strain on the pelvic connective tissues can lead to a myriad of pelvic floor disorders [9,10]. PFPT aims to restore normal pelvic muscle strength, endurance, power, resting tone or a combination of these to reverse damage to the muscles and connective tissue [11].


A good understanding of pelvic anatomy and neurophysiology is critical to accurate diagnosis and management with appropriate physical therapy techniques. The deep pelvic floor muscles include the coccygeus muscles and the levator ani muscle complex, including the puborectalis, pubococcygeus, and iliococcygeus muscles (Fig. 1). These muscles maintain pelvic floor tone and protect the connective tissues from excess load [12]. The superficial pelvic floor muscles, also known as the urogenital diaphragm, include the bulbospongiosus, ischiocavernosus, superficial and deep transverse perineal muscles, fascial layers, and urethral and anal sphincters. The perineal body or central perineal tendon is the convergence of the superficial pelvic muscles and sphincters and provides support to the pelvic floor [13]. The obturator internus and piriformis muscles are muscles of the pelvic side walls and externally rotate the femur [14]. The pelvic floor muscles are innervated by sacral nerve roots, the pudendal nerve, and the levator ani nerve. These nerves and the pelvic floor muscles, which are 70% slow-twitch, striated skeletal muscle, provide nearly constant muscle tone to the pelvic floor, maintaining urinary and fecal continence [15].

Superficial and deep muscles of the pelvic floor. The deep pelvic floor muscles include the coccygeus muscles and the levator ani muscle complex, including the puborectalis, pubococcygeus, and iliococcygeus muscles. The superficial pelvic floor muscles, also known as the urogenital diaphragm, include the bulbospongiosus, ischiocavernosus, superficial and deep transverse perineal muscles, fascial layers, and urethral and anal sphincters [16].


PFPT examination and treatment include both internal and external components. During external examination, the lumbosacral and sacroiliac joints, iliopsoas and piriformis muscles, iliacus and rectus abdominis muscle insertions, and abdominal viscera and bladder are palpated for points of tenderness. An exam for diastasis recti abdominus, abdominal hernia, and inguinal hernia is also performed. During internal examination, pelvic floor muscles are assessed for tone, elasticity, and areas of tenderness and pain [17▪]. The examiner also evaluates the patient's ability to perform voluntary contraction and voluntary relaxation, assessing coordination, muscle length, strength, and endurance. An assessment for POP and pelvic floor descent with Valsalva maneuver is also performed. The rest of the internal examination includes palpation of the obturator internus, pudendal nerve in Alcock's canal, periurethral connective tissue, and vulva. Following examination, the physical therapist will link the objective findings to specific symptoms and devise a treatment plan.


In addition to manual manipulation, modalities such as electrostimulation, biofeedback, and vaginal dilators or vaginal weighted cones can be used to help with isolation of pelvic floor musculature and improve contraction [18–21].

Biofeedback equipment. Biofeedback uses a vaginal or rectal pressure sensor to provide an audible and/or visual feedback of the strength of the muscle contraction.
  1. Electrical stimulation provides a small electrical current to contract the pelvic floor and assist the patient in isolation of the proper muscles.
  2. Biofeedback uses a vaginal or rectal pressure sensor to provide an audible and/or visual feedback of the strength of the muscle contraction (Fig. 2).
  3. A vaginal weighted cone is inserted into the vagina and held in place by pelvic muscle contractions during activity.


Stress urinary incontinence

Stress urinary incontinence (SUI) is the involuntary loss of urine associated with increased intra-abdominal pressure during activities, such as coughing, laughing, sneezing, impact movements or squatting [6,22]. It affects 25–45% of women [23,24]. Pelvic floor muscle contraction can increase urethral pressure and elevate the urethra under the pubic symphysis to maintain continence and prevent urinary leakage. PFPT is used to strengthen and support the pelvic floor structures to improve SUI [25].

A recent 2018 Cochrane Review assessed 31 randomized controlled trials (RCTs) of PFPT for women with urinary incontinence. Women with SUI who were in the PFPT groups were eight times more likely to report cure (56 versus 6%; risk ratio 8.38) and six times more likely to report cure or improvement (74 versus 11%; risk ratio 6.33) than women in the placebo, sham, or no treatment groups [26▪▪]. A 2019 systematic review of 11 RCTs of PFPT with biofeedback versus conservative treatment found that biofeedback did not offer additional symptom improvement in women with SUI [27▪]. In two single-blinded RCTs, however, the highest cure rates were in the treatment arms of combined PFPT with biofeedback and electrical stimulation. These studies also had close follow-up every 1–2 weeks, high adherence and low drop-out rates. It is likely that the key factors for successful SUI treatment with PFPT are close follow-up and intensive training [28,29].

Overactive bladder

Overactive bladder syndrome is a constellation of symptoms including urinary urgency, frequency, urgency incontinence (UUI) and nocturia [30]. These symptoms are caused by involuntary contractions of the bladder detrusor muscle. Studies have shown that pelvic floor activation can inhibit bladder contraction [31]. One theory suggests that pelvic floor muscle contraction can improve conscious control of bladder function by activating the frontal cortex of the brain, which is responsible for the voluntary urinary inhibition reflex [32]. A second theory suggests that pelvic floor activation of the puborectalis and the external urethral and anal sphincters can relax the detrusor muscle via mechanisms of reciprocal inhibition [33]. PFPT can be used in the management of UUI by activating pelvic floor muscles to inhibit detrusor overactivity and avoid urinary leakage.

In the 2018 Cochrane Review only one of the 31 RCTs evaluated cure or improvement in UUI [26▪▪]. In this study, women who underwent PFPT had fewer leakage episodes in 24 h than women without treatment (0.77 episodes versus 2.6 episodes, mean difference −1.83, 95% confidence interval −2.65 to −1.01) [34]. A 2012 systematic review identified 13 RCTs comparing PFPT with no treatment for UUI, all of which showed some improvement in UUI with PFPT [35]. These improved outcomes suggest PFPT is a viable treatment for UUI, however, there was considerable variability in the level of improvement and more robust data is needed.

Pelvic organ prolapse

Pelvic floor physical therapy for nonsurgical pelvic organ prolapse

POP occurs when there is weakness of the pelvic floor and connective tissue attachments to the bony pelvis allowing abnormal descent or herniation of the pelvic organs (uterus, vaginal apex, bladder, or rectum) from their normal position in the pelvis [36]. Women with POP usually complain of pelvic heaviness, fullness, low back pain, or voiding and/or defecation dysfunction [37]. An ordinal staging system of POP (POP-Q) based on the extent of vaginal wall descent relative to the hymen is used to describe POP severity: stage 0 is no descent, stage 1 is minimal descent, stage 2 is descent within 1 cm of the hymen, stage 3 is descent beyond the hymen but less than 2 cm of full vaginal length, and stage 4 is complete descent of the vaginal walls [38]. By improving muscle strength and coordination with PFPT, the resting position of the uterus, bladder, and rectum can be elevated to decrease symptoms, reduce POP-Q stage, and improve quality of life [39].

The largest study to address PFPT for POP was the Pelvic Organ Prolapse Physiotherapy trial, a multicenter, RCT at 23 centers. Women with newly diagnosed symptomatic stage I, II, or III prolapse were randomized to PFPT or a prolapse lifestyle advice pamphlet. Women in the PFPT group had a significantly greater reduction in POP symptom scores at 12 months (mean reduction from baseline 3.77 versus 2.09, P = 0.0053), and more women in the control group received further treatment within 12 months (risk ratio 2.1, P < 0.0001) [40]. A 2016 meta-analysis of 13 RCTs reported that women who had PFPT for POP had greater improvement in objective POP stage (risk ratio 1.70) and the number of women who reported prolapse improvement was higher (risk ratio 5.48) [41]. The 2013 International Consultation on Incontinence report concluded that there is level 1, grade A evidence to recommend PFMT in treatment of POP [42]. Many of the RCTs showing improved outcomes with PFPT had physical therapy regimes with individualized training and vigorous supervision.

Perioperative and postoperative pelvic floor physical therapy for pelvic organ prolapse and stress urinary incontinence surgery

The lifetime risk of undergoing surgery for prolapse and incontinence is between 11 and 20% [43]. Multiple RCTs have sought to evaluate whether PFPT before and after POP or SUI surgery is associated with any clear benefit [44,45▪▪].

A 2018 systematic review examined perioperative interventions for POP surgery [46▪▪]. In three RCTs, there were no differences in objective surgical failure rates and inconsistent results regarding symptom reduction when comparing patients who had perioperative PFPT and those who did not [47–49]. The largest trial of postoperative PFPT was the Operations and Pelvic Muscle Training in the Management of Apical Support Loss trial, which randomized patients to either uterosacral ligament suspension (USLS) or sacrospinous ligament fixation (SSLF), as well as perioperative behavioral therapy with PFMT (BPMT) or usual care. There were no significant improvements in urinary symptoms at 6 months or prolapse outcomes at 2 years between then BPMT and usual care groups. Although a higher number of patients who underwent USLS and BPMT had apical descent more than 1/3 of the vaginal length at 2 years, there were no significant differences in outcomes between the groups at 5-year analysis [47,50▪▪].

The Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence trial randomized female patients with mixed urinary incontinence (MUI) to either midurethral sling (MUS) surgery and postoperative PFPT or MUS alone. Preliminary results indicate that adding PFPT after MUS surgery results in greater improvements in MUI, higher quality-of-life scores, and fewer incontinence episodes compared with sling alone [45▪▪].

Currently, there is conflicting evidence regarding the effectiveness of perioperative PFPT and it has not been routinely recommended before or after POP surgery. Perioperative PFPT may be helpful after SUI surgery in patients with MUI although data is limited.

Anal incontinence

Anal incontinence, which includes gas, liquid, and stool incontinence, has an estimated prevalence of 2–24% [51]. Fecal incontinence, referred to as accidental bowel leakage, is the involuntary loss of solid or liquid stool [52]. The prevalence of fecal incontinence increases from 2.6% in young women (aged 20–29 years) to 15.3% by age 70 years or older [53]. Half of patients with fecal incontinence also have urinary incontinence [54].

PFPT for fecal incontinence seems to reduce incontinence episodes with the addition of biofeedback in nonrandomized studies [55–57]. A randomized trial of biofeedback compared with either PFPT or advice alone, however, showed no additional benefit from biofeedback [58]. A recent 2016 Cochrane Review did not find any evidence that specific types of biofeedback or exercise were more beneficial than others, but did find that biofeedback or electrical stimulation is more efficacious than PFPT alone in patients who have failed to respond to other measures [59]. PFPT with biofeedback or electrical stimulation seems to be a beneficial first-line treatment for anal incontinence and fecal incontinence.

Peripartum and postpartum period

Pregnancy and childbirth are commonly considered to be major risk factors for women with pelvic floor dysfunction, which can occur in 46% of puerperal women [60]. Among postpartum women, up to 34% report urinary incontinence and 4% report fecal incontinence [61,62].

A 2018 Cochrane Review reviewed 38 RCTs to determine the effectiveness of PFPT in the prevention or treatment of urinary and fecal incontinence in pregnant or postnatal women [63▪▪]. In six RCTs of continent pregnant women, patients who performed antenatal PFPT compared with those who had no PFPT had a lower risk of urinary incontinence in late pregnancy (risk ratio 0.38) and a lower risk of urinary incontinence 3–6 months’ postpartum (risk ratio 0.71). In studies of women at least 6 months postpartum, a decreased risk of urinary incontinence was not seen.

A 2018 meta-analysis analyzed 15 RCTs to determine the effect of postpartum PFPT on POP, sexual function, and fecal incontinence [64▪]. Consistent with previous studies, seven RCTs showed that postpartum women receiving PFPT were less likely report urinary incontinence (risk ratio 0.44) up to 12 months postpartum. Pooling of data from three RCTs showed that women receiving PFPT were less likely to report bothersome POP symptoms between 6 and 12 months postpartum (risk ratio 0.48). Although pooling of data from six RCTs showed that there was an overall trend toward reduction of stage II or greater POP within 12 months postpartum (risk ratio 0.74), these results were not statistically significant. Pooling of data from four RCTs showed a reduction in unsatisfactory sexual function up to 12 months postpartum who received structured PFPT (risk ratio 0.48). Three trials showed no significant difference in fecal incontinence symptoms (risk ratio 1.11). This is consistent with an RCT of patients with Obstetric Anal Sphincter Injury (OASIS) allocated to PFPT or usual care, which showed no difference in quality of life improvements between the two groups [65]. Based on the available evidence, PFPT should be commonly recommended during pregnancy and after birth to prevent and treat urinary incontinence, POP and postpartum sexual dysfunction in the short-term. More evidence is needed to evaluate the effectiveness for PFPT for fecal incontinence, specifically in those postpartum patients with OASIS.


High-tone or hypertonic pelvic floor muscles affect 16% of women and are associated with pelvic floor myofascial pain, dyspareunia, vaginismus, and vulvodynia [66].

Pelvic floor myofascial pain

Pelvic floor myofascial pain disorder is characterized by short, tight, tender pelvic floor muscles with myofascial trigger points causing local and referred pain. Symptoms include chronic vaginal discomfort and dyspareunia [67]. PFPT is considered the first-line therapy of myofascial pain and spasm [68].

Tu et al. performed a 2005 systematic review of two RCTs and 27 observational case series to evaluate the use of manual techniques to alleviate musculoskeletal pelvic pain. Although there was wide variation in PFPT techniques and study size, the authors concluded that 59–80% of women reported improvement in pelvic pain [69]. Oyama et al. performed a nonrandomized study of 21 women with pelvic floor myofascial disorder. Patients had improvement in pain scores after 5 weeks of twice weekly intravaginal myofascial release for up to 4.5 months after treatment (P < 0.05) [70].

Dyspareunia and vaginismus

Dyspareunia is characterized by pain during sexual intercourse or vaginal penetration and vaginismus is characterized by a spasm of the perineal musculature making vaginal penetration difficult [71]. PFPT is an important treatment strategy in the multidisciplinary approach to dyspareunia and vaginismus as it improves muscle relaxation, normalizes resting muscle activity, increases vaginal elasticity, muscle awareness, and proprioception [72▪].

In a 2013 retrospective observational study, Bedaiwy et al. analyzed a cohort of patients with chronic pelvic pain and dyspareunia who received at least 12 sessions of PFPT. Forty-five percent of patients reported improvement in dyspareunia [73]. A more recent 2019 RCT randomized 42 women with dyspareunia to receive PFPT or lower back and abdominal physical therapy. Patients who received PFPT showed significant improvement in pain (P ≤ 0.001), overall quality-of-life scores (P ≤ 0.001), and overall sexual function (P < 0.018), compared with patients who did not have pelvic floor training [74▪]. Reissing et al. retrospectively reviewed and interviewed 53 women with vaginismus who were treated with an average of 29 PFPT therapy sessions. Internal manual techniques were most effective at improving vaginismus symptoms followed by patient education, dilatation exercises, and then home exercises [75].


Vulvodynia is vulvar discomfort, most commonly burning pain, in the absence of other findings or diagnoses [76▪]. Pelvic floor dysfunction can cause tissue hypersensitivity, decreased blood flow, and referred pain to the vulva. PFPT is recommended by the American College of Obstetrics and Gynecology as a treatment strategy for vulvodynia and has been incorporated into the International Consultation of Sexual Medicine's recommendation (grade B) for the management of vulvodynia [77,78].

Gentilcore-Saulnier et al. evaluated women with provoked vestibulodynia prior to PFPT and found that this cohort had higher tonic surface electromyography activity in their superficial pelvic floor muscles as well as a heightened pain response to palpation of pelvic floor muscles compared with a control group of women. After eight PFPT sessions, women with vestibulodynia had less pelvic floor muscle responsiveness to pain, less pelvic floor muscle tone, improved vaginal flexibility, and improved pelvic floor muscle capacity [79].


Although PFPT for the treatment of pelvic floor disorders is a low-risk therapy with a high success rate, patient knowledge and perception of this option is often poor. Patients may dismiss PFPT because of their discomfort about intravaginal exams. Adherence is often very low as patients may be time-restricted and symptoms may only improve after multiple sessions. Extensive patient education regarding treatment details as well as expectations for treatment goals can reduce the negative perception and anxiety surrounding PFPT [80▪–82▪]. Educating clinical staff on the treatment details and providing patient hand-outs can improve compliance. In addition, clinicians and pelvic floor physical therapists should have a good working relationship and communicate frequently and openly about mutual patients.


There are currently no gold standards for PFPT research regarding recommended PFPT modalities, therapy session length, frequency, duration, and intensity. Comparisons of different studies can be difficult and imprecise. A standardized approach to clinical trials of PFPT would allow for easier therapeutic analysis and more robust and useful data.


PFPT is recommended as a first-line, low-risk, minimally invasive therapy for preventing and treating pelvic floor dysfunction. Initial studies have been very promising and more robust research with standardized protocols will be forthcoming for both hypotonic and hypertonic pelvic floor disorders, specifically those that may occur in the peripartum and postpartum period (Table 2).

Table 2
Table 2:
Evidence for conditions treated with pelvic floor physical therapy



Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


Papers of particular interest, published within the annual period of review, have been highlighted as:

  • ▪ of special interest
  • ▪▪ of outstanding interest


1▪. Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Neurourol Urodyn 2017; 36:221–244.

This is a consensus-based terminology report for the conservative management of female pelvic dysfunction and combines the input of members and elected nominees of the Standardization and Terminology Committees of two International Organizations, the International Urogynecological Association, and the International Continence Society.

2. Herbert RD, Jamtvedt G, Mead J, et al. Practical evidence-based physiotherapy. 2nd ed.Oxford: Elsevier; 2011.
3. Fitzgerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. I: Background and patient evaluation. Int Urogynecol J 2003; 14:261–268.
4. Newman DK, Wein AJ. Office-based behavioral therapy for management of incontinence and other pelvic disorders. Urol Clin North Am 2013; 40:613–635.
5. Sung VW, Hampton BS. Epidemiology of pelvic floor dysfunction. Obstet Gynecol Clin North Am 2009; 36:421–443.
6. Haylen B, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29:4–20.
7. DeLancey JO. Anatomy and biomechanics of genital prolapse. Clin Obstet Gynecol 1993; 36:897–909.
8. Norton P. Pelvic floor disorders: the role of fascia and ligaments. Clin Obstet Gynecol 1993; 36:926–938.
9. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998; 25:723–746.
10. Ashton-Miller JA, DeLancey JO. On the biomechanics of vaginal birth and common sequelae. Annu Rev Biomed Eng 2009; 11:163–176.
11. Sampselle CM, Miller JM, Mims BL, et al. Effect of pelvic muscle exercise on transient incontinence during pregnancy and after birth. Obstet Gynecol 1998; 91:406–412.
12. Hull M, Corton MM. Evaluation of the levator ani and pelvic wall muscles in levator ani syndrome. Urol Nurs 2009; 29:225–231.
13. Eickmeyer SM. Anatomy and physiology of the pelvic floor. Phys Med Rehabil Clin N Am 2017; 28:455–460.
14. Giraudet G, Patrouix L, Fontaine C, et al. Three dimensional model of the female perineum and pelvic floor muscles. Eur J Obstet Gynecol Reprod Biol 2018; 226:1–6.
15. Chai T, Steers WD. Neurophysiology of micturition and continence in women. Int Urogynecol J Pelvic Floor Dysfunct 1997; 18:85–97.
16. Corton MM. Anatomy of pelvic floor dysfunction. Obstet Gynecol Clin North Am 2009; 36:401–419.
17▪. Meister MR, Shivakumar N, Sutcliffe S, et al. Physical examination techniques for the assessment of pelvic floor myofascial pain: a systematic review. Am J Obstet Gynecol 2018; 219:497.e1–497.e13.

The systematic review analyzed the literature for examination techniques used to asses pelvic floor myofascial pain in women. Examination components varied significantly among the included studies and a consensus examination guideline was developed based on the available data.

18. Richmond CF, Martin DK, Yip SO, et al. Effect of supervised pelvic floor biofeedback and electrical stimulation in women with mixed and stress urinary incontinence. Female Pelvic Med Reconstr Surg 2016; 22:324–327.
19. Fitz FF, Resende APM, Stupp L, et al. Biofeedback for the treatment of female pelvic floor muscle dysfunction: a systematic review and meta-analysis. Int Urogynecol J 2012; 23:1495–1516.
20. Herderschee R, Hay-Smith EJ, Herbison G, et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2011. CD009252.
21. Seo JT, Yoon H, Kim YH. A randomized prospective study comparing new vaginal cone and FES-biofeedback. Yonsei Med J 2004; 45:879–884.
22. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the ICS. Neurourol Urodyn 2002; 21:167–178.
23. Thom D. Variations in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 1998; 46:473–480.
24. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000; 53:1150–1157.
25. Brostrøm S, Lose G. Pelvic floor muscle training in the prevention and treatment of urinary incontinence in women – what is the evidence? Acta Obstet Gynecol Scand 2008; 87:384–402.
26▪▪. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018; 10:CD005654.

The Cochrane systematic review included 31 trials comparing the effects of pelvic floor physical therapy (PFPT) on urinary incontinence by comparing patients who underwent PFPT to those patients who did not. The authors concluded that PFPT can cure or improve symptoms of stress urinary incontinence (SUI) and all other type of urinary incontinence and suggested that PFPT could be included in the first-line conservative management programes for women with urinary incontinence.

27▪. Nunes EFC, Sampaio LMM, Biasotto-Gonzalez DA, et al. Biofeedback for pelvic floor muscle training in women with stress urinary incontinence: a systematic review with meta-analysis. Physiotherapy 2019; 105:10–23.

In this systematic review with meta-analysis, the authors evaluated 1194 studies to determine if biofeedback is more effective than other interventions for women with SUI. They concluded that PFPT with biofeedback does not offer therapeutic benefits over alternative interventions (no training, PFPT, alone and vaginal electrical stimulation) for the treatment of female SUI.

28. Schmidt AP, Sanches PR, Silva DP, et al. A new pelvic muscle trainer for the treatment of urinary incontinence. Int J Gynecol Obstet 2009; 105:218–222.
29. Fitz FF, Stüpp L, da Costa TF, et al. Outpatient biofeedback in addition to home pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. Neurourol Urodyn 2017; 36:2034–2043.
30. Gormley EA, Lightner DJ, Faraday M, et al. Diagnosis and treatment of overactive bladder (nonneurogenic) in adults: AUA/SUFU Guideline Amendment. J Urol 2015; 193:1572–1580.
31. Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol 2003; 20:374–377.
32. Griffiths D, Clarkson B, Tadic SD, Resnick NM. Brain mechanisms underlying urge incontinence and its response to pelvic floor muscle training. J Urol 2015; 194:708–715.
33. Shafik A. A study on the continent mechanism of the external urethral sphincter with identification of the ‘voluntary urinary inhibition reflex’. J Urol 1999; 162:1967–1971.
34. Firra J, Thompson M, Smith SS. Paradoxical findings in the treatment of predominant stress and urge incontinence: a pilot study with exercise and electrical stimulation. J Women Health Phys Ther 2013; 37:113–123.
35. Greer JA, Smith AL, Arya AL. Pelvic floor muscle training for urgency urinary incontinence in women: a systematic review. Int Urogynecol J 2012; 23:687–697.
36. Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10–17.
37. Tan JS, Lukacz ES, Menefee SA, et al. Predictive value of prolapse symptoms: a large database study. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16:203–209.
38. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2011. CD003882.
39. Hall AF, Theofrastous JP, Cundiff GW, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol 1996; 175:1467–1470.
40. Hagen S, Stark D, Glazener C, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet 2014; 383:796–806.
41. Li C, Gong Y, Wang B. The efficacy of pelvic floor muscle training for pelvic organ prolapse: a systematic review and meta-analysis. Int Urogynecol J 2016; 27:981–992.
42. Dumoulin C, Hunter KF, Moore K, et al. Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: summary of the 5th International Consultation on Incontinence. Neurourol Urodyn 2016; 35:15–20.
43. Wu JM, Matthews CA, Conover MM, et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014; 123:1201–1206.
44. Frawley HC, Phillips BA, Bø K, Galea MP. Physiotherapy as an adjunct to prolapse surgery: an assessor-blinded randomized controlled trial. Neurourol Urodyn 2010; 29:719–725.
45▪▪. Sung VW, Newman DK, Borello-France D, et al. A randomized trial comparing combined midurethral sling and behavioral/pelvic floor therapy to midurethral sling alone for mixed urinary incontinence – the ESTEEM trial. Female Pelvic Med Reconstr Surg 2018; 24:S1.

The authors conducted a randomized, multicenter trial of midurethral sling (MUS) and PFPT versus MUS alone for the treatment of mixed urinary incontinence. They found that combined MUS and PFPT is associated with greater improvements in urinary symptoms and quality of life compared with MUS alone.

46▪▪. Haya N, Feiner B, Baessler K, et al. Perioperative interventions in pelvic organ prolapse surgery. Cochrane Database Syst Rev 2018; 8:CD013105.

The Cochrane Systematic review analyzed 15 randomized controlled trials (RCTs) to compare the safety and effectiveness of a range of perioperative interventions versus no interventions at the time of surgery for pelvic organ prolapse (POP). The authors found that a structured programe of PFPT before and after prolapse surgery did not consistently demonstrate any benefit for the intervention.

47. Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA 2014; 311:1023–1034.
48. McClurg D, Hilton P, Dolan L, et al. Pelvic floor muscle training as an adjunct to prolapse surgery: a randomised feasibility study. Int Urogynecol J 2014; 25:883–891.
49. Pauls RN, Crisp CC, Novicki K, et al. Impact of physical therapy on quality of life and function after vaginal reconstructive surgery. Female Pelvic Med Reconstr Surg 2013; 19:271–277.
50▪▪. Jelovsek JE, Barber MD, Brubaker L, et al. Effect of uterosacral ligament suspension vs sacrospinous ligament fixation with or without perioperative behavioral therapy for pelvic organ vaginal prolapse on surgical outcomes and prolapse symptoms at 5 years in the OPTIMAL randomized clinical trial. JAMA 2018; 319:1554–1565.

In this study, the authors conducted a 2 × 2 factorial randomized clinical trial at nine US medical centers to compare outcomes in women randomized to USLS or SSLF and usual care perioperative behavioral therapy and pelvic floor muscle training (PFMT) for vaginal apical prolapse. Among women who had undergone vaginal surgery for apical pelvic organ vaginal prolapse, there was no significant difference between USLS and SSLF in rates of surgical failure and no significant difference between perioperative behavioral muscle training and usual crae on rates of anatomic success and symptom scores at 5 years.

51. Bharucha AE, Dunivan G, Goode PS, et al. Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop. Am J Gastroenterol 2015; 110:127–136.
52. Ng KS, Sivakumaran Y, Nassar N, Gladman MA. Fecal incontinence: community prevalence and associated factors – a systematic review. Dis Colon Rectum 2015; 58:1194–1209.
53. Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009; 137:512–517.
54. Matthews CA, Whitehead WE, Townsend MK, Grodstein F. Risk factors for urinary, fecal, or dual incontinence in the Nurses’ Health Study. Obstet Gynecol 2013; 122:539–545.
55. Ko CY, Tong J, Lehman RE, et al. Biofeedback is effective therapy for fecal incontinence and constipation. Arch Surg 1997; 132:829–833.
56. Ryn AK, Morren GL, Hallböök O, Sjödahl R. Long-term results of electromyographic biofeedback training for fecal incontinence. Dis Colon Rectum 2000; 43:1262–1266.
57. Norton C, Kamm MA. Anal sphincter biofeedback and pelvic floor exercises for faecal incontinence in adults – a systematic review. Aliment Pharmacol Ther 2001; 15:1147–1154.
58. Norton C, Chelvanayagam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003; 125:1320–1329.
59. Norton C, Cody JD. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 2012; 7:CD002111.
60. Handa VL, Nygaard I, Kenton K, et al. Pelvic organ support among primiparous women in the first year after childbirth. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:1407–1411.
61. Burgio KL, Borello-France D, Richter HE, et al. Risk factors for fecal and urinary incontinence after incontinence after childbirth childbirth and pelvic symptoms study. Am J Gastroenterol 2007; 102:1998–2004.
62. Soligo M, Livio S, De Ponti E, et al. Pelvic floor assessment after delivery: how should women be selected? Eur J Obstet Gynecol Reprod Biol 2016; 206:153–157.
63▪▪. Woodley SJ, Boyle R, Cody JD, et al. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2017; 12:CD007471.

The Cochrane systematic review analyzed 138 trials to determine the effectiveness of PFMT in the prevention or treatment of urinary and fecal incontinence in pregnant or postnatal women. The authors found that targeting continent antenatal women early in pregnancy and offering a structured PFMT programe may prevent the onset of urinary incontinence in late pregnancy and postpartum. Few data exist on fecal incontinence.

64▪. Wu YM, McInnes N, Leong Y. Pelvic floor muscle training versus watchful waiting and pelvic floor disorders in postpartum women: a systematic review and meta-analysis. Female Pelvic Med Reconstr Surg 2018; 24:142–149.

The study analyzed 15 RCTs comparing PFPT versus watchful waiting in women with stage 2 or less POP within 1-year postpartum. The authors found that postpartum PFPT reduces the risk of urinary incontinence, particularly SUI syptoms.

65. Oakley SH, Ghodsi VC, Crisp CC, et al. Impact of pelvic floor physical therapy on quality of life and function after obstetric anal sphincter injury: a randomized controlled trial. Female Pelvic Med Reconstr Surg 2016; 22:205–213.
66. Mathias SD, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87:321–327.
67. Tu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain: a systematic review of existing therapies: Part I. Obstet Gynecol Surv 2005; 60:474–483.
68. Reiter RC. Evidence-based management of chronic pelvic pain. Clin Obstet Gynecol 1998; 41:422–435.
69. Tu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain: a systematic review of existing therapies: Part II. Obstet Gynecol Surv 2005; 60:474–483.
70. Oyama IA, Rejba A, Lukban JC, et al. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004; 64:862–865.
71. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed.Arlington, VA: American Psychiatric Association; 2013.
72▪. Bradley MH, Rawlins A, Brinker CA. Physical therapy treatment of pelvic pain. Phys Med Rehabil Clin N Am 2017; 28:589–601.

In this article, the authors discusses how the trained pelvic floor physical therapist assesses and treats patients with chronic pelvic pain.

73. Bedaiwy MA, Patterson B, Mahajan S. Prevalence of myofascial chronic pelvic pain and the effectiveness of pelvic floor physical therapy. J Reprod Med 2013; 58:504–510.
74▪. Schvartzman R, Schvartzman L, Ferreira CF, et al. Physical therapy intervention for women with dyspareunia: a randomized clinical trial. J Sex Marital Ther 2019; 45:378–394.

In this study, the authors performed a randomized trial of either PFPT or lower back with myofascial release in climacteric women aged between 40 and 60 years old who were sexually active and had complaints of dyspareunia. PFPT was effective to improve pain, quality of life, sexual function, and pelvic floor muscle function in climacteric women with dyspareunia.

75. Reissing ED, Armstrong HL, Allen C. Pelvic floor physical therapy for lifelong vaginismus: a retrospective chart review and interview study. J Sex Marital Ther 2013; 39:306–320.
76▪. Bornstein J, Preti M, Simon JA, et al. Descriptors of vulvodynia: a multisocietal definition consensus (the International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society). J Low Genit Tract Dis 2019; 23:161–163.

The article details the definitions of vulvodynia descriptors as determined by a multistaged process of discussion among healthcare providers with expertise in the pathophysiology, evaluation, and treatment of vulvodynia.

77. Committee opinion no 673 summary: persistent vulvar pain. Obstet Gynecol 2016; 128:676–677.
78. Goldstein AT, Pukall CF, Brown C, et al. Vulvodynia: assessment and treatment. J Sex Med 2016; 13:572–590.
79. Gentilcore-Saulnier E, McLean L, Goldfinger C, et al. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J Sex Med 2010; 7:1003–1022.
80▪. Zoorob D, Higgins M, Swan K, et al. Barriers to pelvic floor physical therapy regarding treatment of high-tone pelvic floor dysfunction. Female Pelvic Med Reconstr Surg 2017; 23:444–448.

In this study, the authors surveyed 70 patients to identify barriers preventing patients from following through with PFPT. Major barriers included insurance noncoverage, time constraints, anxiety, and unclear explanations of the treatment.

81▪. Shannon MB, Adams W, Fitzgerald CM, et al. Does patient education augment pelvic floor physical therapy preparedness and attendance? A randomized controlled trial. Female Pelvic Med Reconstr Surg 2018; 24:155–160.

The authors performed a RCT of 200 patients undergoing PFPT who either received standard handout counseling or enhanced video counseling. Enhanced video counseling did not improve patient preparedness or odds of attending PFPT.

82▪. Venegas M, Carrasco B, Casas-Cordero R. Factors influencing long-term adherence to pelvic floor exercises in women with urinary incontinence. Neurourol Urodyn 2018; 37:1120–1127.

The authors in this observational, descriptive, cross-sectional study attempted to identify the factors that influence long-term adherence to pelvic floor exercises in women with urinary incontinence. Sixty-one women participated in this study. Forgetting to do the exercises and boredom with the exercises were the factors most strongly related to low treatment adherence.


hypertonic pelvic floor disorders; pelvic floor dysfunction; pelvic floor physical therapy; pelvic organ prolapse; urinary incontinence

Copyright © 2019 YEAR Wolters Kluwer Health, Inc. All rights reserved.